Futura Medical plc (FAMDF)
- Previous Close
0.1100 - Open
0.1000 - Bid 0.1000 x --
- Ask 0.1500 x --
- Day's Range
0.1000 - 0.1000 - 52 Week Range
0.0100 - 0.6000 - Volume
3,000 - Avg. Volume
7,680 - Market Cap (intraday)
35.648M - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
10.00 - EPS (TTM)
0.0100 - Earnings Date Apr 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
www.futuramedical.comRecent News: FAMDF
View More
Performance Overview: FAMDF
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FAMDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FAMDF
View MoreValuation Measures
Market Cap
35.65M
Enterprise Value
26.87M
Trailing P/E
18.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.68
Price/Book (mrq)
2.55
Enterprise Value/Revenue
1.45
Enterprise Value/EBITDA
14.79
Financial Highlights
Profitability and Income Statement
Profit Margin
9.28%
Return on Assets (ttm)
6.12%
Return on Equity (ttm)
17.91%
Revenue (ttm)
13.93M
Net Income Avi to Common (ttm)
1.29M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
6.6M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.59M